XOMAP Q4 2022 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-95.9% YoY

Gross Profit

$1M98.1% margin

Operating Income

-$6M-417.9% margin

Net Income

-$6M-402.2% margin

EPS (Diluted)

$-0.52

QoQ Revenue Growth

+229.5%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$140M

Total Liabilities

$16M

Stockholders' Equity

$124M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$36M	-95.9%
Gross Profit	$1M	$36M	-95.9%
Operating Income	-$6M	$30M	-120.5%
Net Income	-$6M	$30M	-120.0%